Immediate access to CD4 T cells results may also enable more rapid initiation of prophylactic treatment for opportunistic infections as well as chemotherapy for prevention of mother-to-child transmission at sites where CD4 T lymphocytes levels define the prophylactic drug regimen [10,11]. The gene discussed is CD4; the disease is Opportunistic infection.